Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats

International Journal of Tissue Reactions

Volumn 20, Issue 2, 1998, Pages 45-56

  Nakajima, S ^a   Majima, M ^a,b   Ito, H ^a   Hayashi, I ^a   Yajima, Y ^a   Katori, M ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BP 102; BRADYKININ; DEOXYCORTICOSTERONE ACETATE; ENKEPHALINASE INHIBITOR; KININ; KININASE; KININOGEN; SODIUM; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART WEIGHT; HYPERTENSION; MALE; NATRIURESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SODIUM URINE LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ATRIAL NATRIURETIC FACTOR; DESOXYCORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; HEART; HYPERTENSION; KIDNEY; KININOGENS; KININS; MALE; NEPRILYSIN; ORGAN SIZE; PRODRUGS; RATS; RATS, INBRED BN; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; THIORPHAN; TIME FACTORS;

ANIMALIA;

EID: 0032419879     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Erdos E.G., Skidgel R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J., 3, 145, 1989.
2. Hirata Y., Suzuki Y., Suzuki E., et al. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. J. Hypertens., 12, 367, 1994.
3. Wilkins M.R., Unwin R.T., Kenny A.J. Endopeptidase-24.11 and its Inhibitors: potential therapeutic agents for edematous disorders and hypertension. Kidney Int., 43, 273, 1993.
4. Scicli A.G., Carretero O.A. Renal kallikrein-kinin system. Kidney Int., 29, 120, 1986.
5. 3H]bradykinin in isolated nephron segments of the rabbit. Am. J. Physiol., 246, 732, 1984.
6. Margolius H.S., Geller R., de Jong W., Pisano J.J., Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet, 2, 1063, 1971.
7. Berry T.D., Hasstedt S.J., Hunt S.C., et al. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13, 3, 1989.
8. Ader J.L., Pollock D.M., Butterfield M.I., Arendshorst W. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am. J. Physiol., 248 (3 Pt 2), F396, 1985.
9. Arbeit LA., Serra S.R. Decreased total and active urinary kallikrein in normotensive Dahl salt susceptible rats. Kidney Int., 28, 440, 1985.
10. Majima M., Katori M., Hanazuka M., et al. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 17(6 Pt 1), 806, 1991.
11. Majima M., Shima C., Saito M., Kuribayashi Y., Katori M., Aoyagi T. Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine. Eur. J. Pharmacol., 232, 181, 1993.
12. Majima M., Adachi K., Ohno T., et al. Failure of the oxytocin-induced increase in secretion of urinary kallikrein in young spontaneously hypertensive rats. Jpn. J. Pharmacol., 71, 11, 1996.
13. Majima M., Yoshida O., Mihara H., et al. High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. J. Hypertension 22, 705, 1993.
14. Majima M., Mizogami S., Kuribayashi Y., Katori M., Ohishi S. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24, 111, 1994.
15. Marumo F., Sakamoto H., Ando K., Ishigami T., Kawakami M. A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine. Biochem. Biophys. Res. Commun., 137, 231, 1986.
16. Roques B.P., Fournie-Zaluski M.C., Soroca E., et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature, 288 (5788), 286, 1980.
17. Roques B.P., Beaumont A. Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives? Trends Pharmacol. Sci., 11, 245, 1990.
18. Wilkins M.R., Unwin R.J., Kenny A.J. Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension. Kidney Int., 43, 273, 1993.
19. Majima M., Adachi K., Kuribayashi Y., Mizogami S., Katori M. Increase in vascular sensitivity to angiotensin II and norepinephrine after four-day infusion of 0.3 M sodium chloride in conscious kininogen-deficient brown Norway Katholiek rats. Jpn. J. Pharmacol., 69, 149, 1995.
20. Hayashi I., Hoshiko S., Makabe O., Oh-ishi S. A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats. J. Biol. Chem., 268, 17219, 1993.
21. 2-receptor blockade facilitates deoxycorticosteronesalt hypertension. Hypertension 21 (6 Pt 2), 980, 1993.
22. Hirata Y., Matsuoka H., Hayakawa H., et al. Role of endogenous atrial natriuretic peptide in regulating sodium excre-lion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition. Hypertension 17 (6 Pt 2), 1025, 1991.
23. Ishida H., Scicli A.G., Carretero O.A. Contributions of various rat plasma peptidases to kinin hydrolysis. J. Pharmacol. Exp. Ther., 251, 817, 1989.
24. Saito M., Majima M., Katori M., et al. Degradation of bradykinin in human urine by carboxypeptidase Y-like exopeptidase and neutral endopeptidase and their inhibition by ebelactone B and phosphoramidon. Int. J. Tissue React., 17, 181, 1995.
25. Burnier M., Ganslmayer M., Perret F., et al. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers. Clin. Pharmacol. Ther., 50, 181, 1991.
26. Kawaguchi S., Uchida K., Ito T., et al. Immunohistochemical localization of atrial natriuretic peptide receptor in bovine kidney and lung. J. Histochem. Cytochem., 37, 1739, 1989.
27. 2+ transients in isolated renal cortical thick ascending limb cells. Am. J. Physiol., 265 (4 Pt 2), F592, 1993.
28. Levin E.R. Natriuretic peptide C-receptor: more than a clearance receptor. Am. J. Physiol., 264(4 Pt 1), E483, 1993.